Immunodeficiency and Prognosis in Patients with Non-Hodgkin's Lymphomas

Authors

  • C. Lindemalm RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN
  • P. Biberfeld RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN
  • M. Björkholm RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN
  • G. Holm RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN
  • B. Johansson RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN
  • H. Mellstedt RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN
  • B. Nilsson RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN
  • å. öst RADIUMHEMMET AND THE DEPARTMENTS OF RADIATION BIOLOGY, PATHOLOGY AND CANCER EPIDEMIOLOGY, KAROLINSKA SJUKHUSET, S-10401, STOCKHOLM; THE DEPARTMENT OF MEDICINE, DANDERYDS SJUKHUS, S-182 88, DANDERYD; THE DEPARTMENT OF CLINICAL IMMUNOLOGY, HUDDINGE SJUKHUS, S-141 86, HUDDINGE, SWEDEN

DOI:

https://doi.org/10.3109/02841868509134380

Abstract

Monocyte depleted blood lymphocyte subpopulations, their functions and relation to prognosis were studied in 68 untreated adult patients with non-Hodgkin's lympho-mas classified according to the Kiel nomenclature. The median observation time was 48 months (range 41–60). The mean total blood lymphocyte and T (SRBC-rosetting) cell counts were signiticantly decreased as compared with age-matched controls (n=57). Twenty-five per cent of the patients had a monoclonal blood B lymphocyte population. The spontaneous lymphocyte DNA synthesis, measured as incorporation of 14C-thymidine, was increased and the response to mitogen and antigen stimulation was decreased. Blood lymphocyte counts and functions before treatment were not related to the rates of remission or survival.

Downloads

Download data is not yet available.

Downloads

Published

1985-01-01

How to Cite

Lindemalm, C., Biberfeld, P., Björkholm, M., Holm, G., Johansson, B., Mellstedt, H., … öst, å. (1985). Immunodeficiency and Prognosis in Patients with Non-Hodgkin’s Lymphomas. Acta Oncologica, 24(2), 159–165. https://doi.org/10.3109/02841868509134380

Issue

Vol. 24 No. 2 (1985): Acta Radiologica: Oncology

Section

Articles